Patient dies after exposure to West Nile from transfusion

08/9/2013 | MedPage Today (free registration)

In the first known such case, an immunocompromised patient died after exposure to West Nile virus through blood products. A minipool of six blood donations was implicated. Blood products have been screened for West Nile since 2003. In this case, the individual samples tested negative but the pool was reactive for the virus, a situation deemed acceptable for transfusion by the FDA. Moving forward, minipools in which the reactive donation can't be identified and removed will be discarded.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX